Stephen Yoo, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 40,321 shares at $59.62 ($2.4M) on 2018-12-03, disclosed to the SEC on 2018-12-06.
Open-market sale of $2.4M RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.62 | 6,854 | $409K | 16.9% |
| 2 | $59.62 | 6,854 | $409K | 16.9% |
| 3 | $60.35 | 13,053 | $788K | 32.5% |
| 4 | $60.35 | 13,053 | $788K | 32.5% |
| 5 | $61.20 | 507 | $31K | 1.3% |
| Total | $60.11 avg | 40,321 |
| $2.4M |
| 100% |
| Filing → |
| RGNX | SELL | 2018-10-31 | $2.3M | — | Filing → |
| RGNX | SELL | 2018-10-17 | $1.9M | — | Filing → |
| RGNX | SELL | 2017-09-12 | $684K | — | Filing → |